Day: April 30, 2016
PHARMACEUTICALS
Denmark's Novo Nordisk says US launch 'encouraging'
The world's largest maker of diabetes treatments, Novo Nordisk, said on Friday that the US launch of ultra-long acting insulin Tresiba had been "encouraging" as it reported a drop in first quarter profit.